Department of chemistry, Samarth Institute of Pharmacy, Belhe, Pune 412410, Maharashtra, India.
Fungal infections, particularly those caused by Candida albicans (ATCC 10231), pose significant challenges due to increasing resistance and the adverse effects of existing treatments. This study investigates the synthesis and characterization of novel naphthalene Hydrazone compounds as possible squalene epoxidase inhibitors with enhanced antifungal activity. The derivative were synthesized, and their progress was monitored using thinlayer chromatography (TLC). The characterization of the compounds involved melting point analysis and various spectroscopic techniques including infrared (IR) spectroscopy. The antifungal efficacy of compounds was evaluated specifically against Candida albicans (ATCC 10231), with Napthalene hydrazone derivative showing superior activity compared to standard antifungal agents naftifine and nystatin. This research lays a promising foundation for the development of novel antifungal therapies, addressing the urgent need for more effective treatments with fewer side effects.
Fungal Infections:
Fungal infections, also known as mycoses, are infections caused by fungi. Fungi can live in soil, on plants, and on household surfaces and skin. While many fungi are harmless, some can cause disease under specific conditions, particularly when the immune system is weakened. Prevalence of fungal infections:
Impact of Fungal Infections:
Types of fungal infections:
I. Superficial Fungal Infections:
Involves infections by Candida species, commonly affecting the skin, nails, and mucous membranes, such as oral thrush and vaginal yeast infections.
II. Subcutaneous Fungal Infections:
III. Systemic (Invasive) Fungal Infections:
Challenges in treating fungal infections
Fungal infections pose significant challenges to healthcare due to a variety of factors including resistance, limited treatment options, diagnostic difficulties, and the impact on immunocompromised patients. Addressing these challenges requires a comprehensive understanding and innovative approaches.
Antifungal Agents
Antifungal agents play a vital role in controlling and treating fungal infections. These agents target various components of fungal cells to inhibit growth or eradicate the fungi, thereby alleviating symptoms and preventing the spread of infection. The classification of antifungal agents is determined by their mechanism of action and chemical properties. However, their use is limited by various factors, including resistance development and side effects.
Classification of Antifungal Agents:
Antifungal agents are broadly classified into the following categories:
Limitations of Antifungal Agents:
Squalene Epoxidase: A Multifaceted Therapeutic Target
Squalene epoxidase (SE) is an essential enzyme in the sterol biosynthesis pathway, catalyzing the first oxygenation step of squalene to 2,3-oxidosqualene. This enzyme plays a crucial role in the biosynthesis of ergosterol in fungi and cholesterol in humans. Due to its pivotal role, SE is a significant target for antifungal, anticancer, and cholesterol-lowering therapies.
Mechanism of Action:
The mechanism of action for squalene epoxidase inhibitors involves the blockage of the enzyme's active site, inhibiting the conversion of squalene to 2,3-oxidosqualene. This results in the buildup of squalene and a subsequent decrease in ergosterol or cholesterol levels. In fungi, Depletion of ergosterol impairs cell membrane integrity and function, which lead to increased permeability and cell death. In humans, inhibition of squalene epoxidase results in lowered cholesterol levels, beneficial in treating hypercholesterolemia.
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-6.png" target="_blank"><img alt="The Mechanism of action of Antifungal Agents.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-6.png" width="150">
</a>
Fig. The Mechanism of action of Antifungal Agents
Squalene Epoxidase Inhibitors as an Antifungal Agent
As an antifungal agent, squalene epoxidase inhibitors are particularly effective against pathogenic fungi like Candida albicans. By inhibiting squalene epoxidase, these agents prevent the production of ergosterol, a essential part of the fungal cell membrane. This disturbance in ergosterol synthesis leads to increased permeability of membranes and fungal cell death.. squalene epoxidase inhibitors are crucial in treating fungal infections resistant to other antifungal drugs.
Squalene Epoxidase Inhibitors and Candida albicans:
squalene epoxidase inhibitors are particularly effective against Candida albicans, a common cause of fungal infections. The inhibition of squalene epoxidase in Candida albicans disrupts ergosterol synthesis, leading to compromised cell membranes and fungal cell death. Terbinafine and other allylamines have shown significant efficacy against Candida albicans, making them valuable in clinical antifungal therapy.
Naphthalene
Naphthalene is a polycyclic aromatic hydrocarbon made up of two fused benzene rings. It is white and crystalline, volatile solid with a distinct smell, commonly used in mothballs and as a chemical intermediate in the production of various compounds. Naphthalene is derived from coal tar and petroleum, and its derivatives are widely used in the pharmaceutical industry due to their diverse biological activities.
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-5.png" target="_blank"><img alt="Resonance Structure of Naphthalene.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-5.png" width="150">
</a>
Fig. Resonance Structure of Naphthalene
Naphthalene-Containing Drugs
Naphthalene derivatives have shown a wide variety of pharmacological properties, which makes them useful for creating medicinal substances. These derivatives are used in the treatment of several diseases, including infections, inflammation, and cancer. Naphthalene-containing drugs often exhibit enhanced stability and bioavailability, contributing to their effectiveness as therapeutic agents.
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-4.png" target="_blank"><img alt="Pharmacological Activities of Naphthalene.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-4.png" width="150">
</a>
Fig. Pharmacological Activities of Naphthalene
Naphthalene-Containing Antifungal Drugs:
Naphthalene derivatives are particularly notable for their antifungal activity. They act by inhibiting key enzymes involved in the synthesis of ergosterol, a crucial part of the fungal cell membranes. This inhibition leads to increased membrane permeability and ultimately results in fungal cell death.
Hydrazones:
A class of chemical compounds known as hydrazones is distinguished by the functional group R1 C=NNHR. They are typically form by the reaction of condensation hydrazines with aldehydes or ketones. Hydrazones have a variety of biological actions, such as antimicrobial, antitumor, anti-inflammatory, and antitubercular properties, which making them valuable scaffolds in medicinal chemistry.
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-3.png" target="_blank">
<img alt="4.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-3.png" width="150">
</a>
Hydrazone-Containing Drug:
Hydrazone derivatives have been developed into various therapeutic agents due to their ability to interact with biological targets through hydrogen bonding, metal coordination, and other interactions. These compounds are versatile in their pharmacological profiles, leading to the development of drugs for different therapeutic applications.
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-2.png" target="_blank"><img alt="Pharmacological Activities of Hydrazones.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-2.png" width="150">
</a>
Fig. Pharmacological Activities of Hydrazones
Naphthalene Hydrazone:
In recent years, naphthalene hydrazone derivatives have attracted a lot of attention because of their wide range of biological activities. These compounds have demonstrated potent antifungal, antibacterial, and anti-inflammatory properties, making them attractive candidates for the development of novel antifungal agents. This study focuses on the synthesis and antifungal evaluation of novel Naphthalene hydrazone derivative.
MATERIALS AND METHODS:
Step 1: Synthesis Of Naphthalene Hydrazine:
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-1.png" target="_blank">
<img alt="Synthesis Of Naphthalene Hydrazine.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-1.png" width="150">
</a>
Take (1.4g ; 0.01mole) beta naphthol in a 250ml RBF. Add 10ml of hydrazine hydrate in it. Add few drops of H2SO4 . Then reflux the mixture for 2hrs. Pour the reaction mixture in crushed ice. Filter the precipitate and recrystallise with ethanol.
Step 2: Synthesis Of Naphthalene Hydrazone Derivatives
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-0.png" target="_blank">
<img alt="Synthesis Of Naphthalene Hydrazone Derivatives.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250428191402-0.png" width="150">
</a>
Take (1.76g; 0.01mole) Naphthalene hydrazine in a 250ml RBF. Add equimolar quantity of substituted benzaldehyde/acetaphenone in it. Add few drops of glacial acetic acid . Add 10ml of ethanol as a solvent. Then reflux the mixture for 4 - 20hrs. Filter the precipitate and recrystallise with ethanol.
TLC: Solvent system (n-hexane-0.8 ml : ethyl acetate-0.2ml)
Antifungal Activity:
Disc Diffusion Method:
The disc diffusion method was used to determine antifungal activity of all test compounds. Saturated solution of all test compounds were prepared in DMSO. Nafitine and Nystatin used as a standard drug to compare the activity of test compounds.
Principle of disc diffusion method
After being suspended in saline and having its turbidity standardized, the pure microbial culture is evenly swabbed on an agar plate. Agar media that has been evenly seeded with the test organism is covered with paper disks that have been impregnated with antibiotics or other substances. Antibiotics spread outward from the disc into the agar during the incubation phase. Diffusion from the disk creates the antibiotic concentration gradient, and the test organism's growth is suppressed at a distance from the disk to the organism's susceptibility. As one gets farther away from the disk, the concentration of these components will drop from its maximum value near the disk. No colonies will form if the concentration in the agar is higher than or equal to the effective concentration of antibiotics if they are effective against microorganisms at a particular concentration. The zone of inhibition is the region surrounding the disc where no growth occurs.
Susceptibility test procedure:
Test Procedure:
Biological Activity: Bactochem Laboratories evaluated the antifungal activity of our synthesized naphthalene hydrazone compounds against Candida albicans (ATCC 10231).
Antifungal Activity
Antifungal evaluation of compound naphthalene hydrazone against Candida albicans revealed their effectiveness, with zone of inhibition compared to naftifine and nystatin.
Compound:
CONCLUSION:
The synthesis of the naphthalene hydrazone was successfully completed, with the reaction monitored by TLC. The newly synthesized compounds were characterized by using melting point analysis, IR spectroscopy, and mass spectrometry, confirming their structures. The synthesis process resulted in high purity and good yields. In vitro antifungal activity was tested against Candida albicans (ATCC 10231), and the results showed that synthesized compound exhibited antifungal activity. The compound demonstrated superior activity compared to the standard drugs naftifine and nystatin. In conclusion, this study lays a strong foundation for the development of novel antifungal agents based on naphthalene hydrazone derivatives. Future research should prioritize optimizing the synthesis process, expanding biological testing, and advancing promising compounds to preclinical and clinical trials. By addressing these areas, the development of effective antifungal therapies can be significantly advanced, contributing to the ongoing efforts to combat fungal infections and overcome the limitations of current treatments.
REFERENCES
Dukare Sakshi*, Badhe Chaitali, Fulsunder A. S., Synthesis and Evaluation of Antifungal Activity of Novel Naphthalene Hydrazone Derivative, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 4, 3173-3183 https://doi.org/10.5281/zenodo.15297090